These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30214154)

  • 1. Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma.
    Zhao YY; Tian Y; Liu L; Zhan JH; Hou X; Chen X; Zhou T; Huang Y; Zhang L
    Drug Des Devel Ther; 2018; 12():2655-2663. PubMed ID: 30214154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo.
    Zhao YY; Tian Y; Zhang J; Xu F; Yang YP; Huang Y; Zhao HY; Zhang JW; Xue C; Lam MH; Yan L; Hu ZH; Dinglin XX; Zhang L
    Drug Des Devel Ther; 2014; 8():1827-37. PubMed ID: 25336925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways.
    Liu L; Huang P; Wang Z; Chen N; Tang C; Lin Z; Peng P
    BMC Cancer; 2016 Oct; 16(1):813. PubMed ID: 27756261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206.
    Cheng Y; Ren X; Zhang Y; Patel R; Sharma A; Wu H; Robertson GP; Yan L; Rubin E; Yang JM
    Cancer Res; 2011 Apr; 71(7):2654-63. PubMed ID: 21307130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines.
    Ma BB; Lui VW; Hui CW; Lau CP; Wong CH; Hui EP; Ng MH; Tsao SW; Li Y; Chan AT
    Invest New Drugs; 2013 Jun; 31(3):567-75. PubMed ID: 23143779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment of mitoxantrone sensitizes breast cancer cells to rapalogs through blocking eEF-2K-mediated activation of Akt and autophagy.
    Guan Y; Jiang S; Ye W; Ren X; Wang X; Zhang Y; Yin M; Wang K; Tao Y; Yang J; Cao D; Cheng Y
    Cell Death Dis; 2020 Nov; 11(11):948. PubMed ID: 33144562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
    Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. eEF-2 kinase, another meddler in the "yin and yang" of Akt-mediated cell fate?
    Cheng Y; Yan L; Ren X; Yang JM
    Autophagy; 2011 Jun; 7(6):660-1. PubMed ID: 21460616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo.
    Hirai H; Sootome H; Nakatsuru Y; Miyama K; Taguchi S; Tsujioka K; Ueno Y; Hatch H; Majumder PK; Pan BS; Kotani H
    Mol Cancer Ther; 2010 Jul; 9(7):1956-67. PubMed ID: 20571069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation.
    Chan KC; Ting CM; Chan PS; Lo MC; Lo KW; Curry JE; Smyth T; Lee AW; Ng WT; Tsao GS; Wong RN; Lung ML; Mak NK
    Mol Cancer; 2013 Oct; 12(1):128. PubMed ID: 24156782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact.
    Devkota AK; Tavares CD; Warthaka M; Abramczyk O; Marshall KD; Kaoud TS; Gorgulu K; Ozpolat B; Dalby KN
    Biochemistry; 2012 Mar; 51(10):2100-12. PubMed ID: 22352903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
    Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
    Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium butyrate induces autophagic apoptosis of nasopharyngeal carcinoma cells by inhibiting AKT/mTOR signaling.
    Huang W; Zeng C; Liu J; Yuan L; Liu W; Wang L; Zhu H; Xu Y; Luo Y; Xie D; Jiang X; Ren C
    Biochem Biophys Res Commun; 2019 Jun; 514(1):64-70. PubMed ID: 31023529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-Thienyl methylene matrine (YYJ18), the derivative from matrine, induces apoptosis of human nasopharyngeal carcinoma cells by targeting MAPK and PI3K/Akt pathways in vitro.
    Xie M; Yi X; Wang R; Wang L; He G; Zhu M; Qi C; Liu Y; Ye Y; Tan S; Tang A
    Cell Physiol Biochem; 2014; 33(5):1475-83. PubMed ID: 24854624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
    Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L
    Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinoma.
    Yang F; Qian XJ; Qin W; Deng R; Wu XQ; Qin J; Feng GK; Zhu XF
    PLoS One; 2013; 8(3):e59879. PubMed ID: 23533654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyphyllin G induce apoptosis and autophagy in human nasopharyngeal cancer cells by modulation of AKT and mitogen-activated protein kinase pathways in vitro and in vivo.
    Chen JC; Hsieh MJ; Chen CJ; Lin JT; Lo YS; Chuang YC; Chien SY; Chen MK
    Oncotarget; 2016 Oct; 7(43):70276-70289. PubMed ID: 27602962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway.
    Guo S; Zhang J; Wei C; Lu Z; Cai R; Pan D; Zhang H; Liang B; Zhang Z
    Cancer Chemother Pharmacol; 2020 Jun; 85(6):1097-1108. PubMed ID: 32449143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arenobufagin induces cell apoptosis by modulating the cell cycle regulator claspin and the JNK pathway in nasopharyngeal carcinoma cells.
    Ho HY; Chen MK; Lin CC; Lo YS; Chuang YC; Hsieh MJ
    Expert Opin Ther Targets; 2024 May; 28(5):461-471. PubMed ID: 38659296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual PI3K/mTOR inhibitors, GSK2126458 and PKI-587, suppress tumor progression and increase radiosensitivity in nasopharyngeal carcinoma.
    Liu T; Sun Q; Li Q; Yang H; Zhang Y; Wang R; Lin X; Xiao D; Yuan Y; Chen L; Wang W
    Mol Cancer Ther; 2015 Feb; 14(2):429-39. PubMed ID: 25504751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.